FDA Proposes New Drug Review Projects

February 2007

The Food and Drug Administration (FDA) announced a variety of projects addressing the need to pay more attention to drugs already on the market. The announcement comes in response to an Institute of Medicine report, released last September, which criticized the agency’s lack of attention to problematic drugs.

The tentative FDA projects include:

• Collaborating with the Veterans Health Administration to share information and expertise about medical products.
• Producing safety profiles of new drugs after they have been on the market for 18 months.
• Posting newsletters on the FDA website updating consumers about post-marketing reviews of drugs.
• Establishing a committee of outside experts advising the FDA about how to handle communicating risks to the public.
• Improving communication between FDA employees who review drugs before approval and those who track the safety of the drugs afterward.

These proposed projects would require more money and regulatory authority, but would allow the FDA more oversight of drugs already being prescribed in the US.

Have You Suffered Injuries Due to a Dangerous Drug? Contact Us Now For a Free Evaluation of Your Legal Case.

Call us toll-free at 1-866-943-3427 or get online legal help, and we'll give you a free evaluation of your claim.